Clearpoint Neuro Inc (CLPT) Stock Price, Quote & News

Company Profile

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration a...

Industry: Medical Devices

Sector: Healthcare

Phone: 888 287 9109

Website: www.clearpointneuro.com

Address:

120 S. Sierra Avenue, Suite 100, Solana Beach, United States

DekmarTrades Oct. 27 at 3:33 PM

$RKLB $CLPT $BWXT 4pm Today.

1 · Reply

mhill771 Oct. 26 at 5:11 PM

$CLPT 50 in due time

0 · Reply

makny Oct. 24 at 3:22 PM

$CLPT this has become an ideal stock for day trade, giving at least $0.50 daily.

0 · Reply

DekmarTrades Oct. 24 at 2:28 PM

$RKLB $CLPT $BWXT I will be 100% giving this Alert away on Monday. I just want to do some final research first. It is important to me that if I make a statement like this, I back it up.

3 · Reply

HiIdontcareThx Oct. 24 at 1:51 PM

$CLPT long-time bull. Added more.

1 · Reply

junboi Oct. 24 at 12:57 PM

$BWXT $CLPT $RKLB oops didn’t add you @DekmarTrades

0 · Reply

junboi Oct. 24 at 12:54 PM

$BWXT $CLPT $RKLB Dek, First: mad props for your transparency to your followers. (Rare) 2nd: this is the main reason I follow you Last: I have to ask is this a marketing tactic? I like but no reply or time frame of future response. Either way: your banking that is the goal here. 👍🏽😎

1 · Reply

NY2CHI Oct. 24 at 12:26 AM

$CLPT recognized in Time as a growth leader in USA https://time.com/7327022/americas-growth-leaders-2025/

0 · Reply

DekmarTrades Oct. 23 at 9:57 PM

Every now and then, I come across a stock that I just can not believe it is trading at the price its at. I come across "GEMS" like this once a year. For example: I found, $RKLB at $9 $CLPT at $11 $BWXT at $80 And now this one. If you LIKE this tweet I will share it with you.

8 · Reply

NY2CHI Oct. 23 at 7:01 PM

$CLPT speaking of people who know nothing about this business, or how markets work, how's our girl @healthcareguru micro McGuire hanging in there? You doing okay, babe? You and @Twister8 should spend some time together, I'll buy your drinks.

0 · Reply

ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles

Oct 6, 2025, 4:10 PM EDT - 20 days ago

ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide

Oct 2, 2025, 5:05 PM EDT - 24 days ago

ClearPoint Neuro: AMT-130 Highlights A Bright Future

Oct 1, 2025, 4:05 PM EDT - 25 days ago

ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System

Sep 25, 2025, 5:50 PM EDT - 4 weeks ago

ClearPoint Neuro: Selling The Tools For Brain Therapies

Sep 25, 2025, 4:05 PM EDT - 4 weeks ago

ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer

Sep 4, 2025, 4:05 PM EDT - 7 weeks ago

ClearPoint Neuro Announces FDA Clearance Expanding Compatibility of the ClearPoint Prism Neuro Laser Therapy System with 1.5T MRI Scanners

Aug 14, 2025, 10:22 PM EDT - 2 months ago

ClearPoint Neuro: Biopharma Momentum Continues To Build

Aug 12, 2025, 10:31 PM EDT - 2 months ago

ClearPoint Neuro, Inc. (CLPT) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 4:05 PM EDT - 2 months ago

ClearPoint Neuro Reports Second Quarter 2025 Results

Aug 4, 2025, 4:05 PM EDT - 2 months ago

ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio

Jul 23, 2025, 4:05 PM EDT - 3 months ago

ClearPoint Neuro to Announce Second Quarter 2025 Results August 12, 2025

Jun 27, 2025, 5:46 PM EDT - 4 months ago

ClearPoint Neuro: Consumables Growth Is Promising

May 20, 2025, 5:47 AM EDT - 5 months ago

I Missed The Quantum Rally - I Won't Miss The Next One

AMSC AUTL CAPR EDIT NTLA VANI VERV

May 13, 2025, 10:02 PM EDT - 5 months ago

ClearPoint Neuro, Inc. (CLPT) Q1 2025 Earnings Call Transcript

May 13, 2025, 4:40 PM EDT - 5 months ago

ClearPoint Neuro Reports First Quarter 2025 Results

May 12, 2025, 4:05 PM EDT - 5 months ago

ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing

Apr 29, 2025, 12:00 AM EDT - 6 months ago

ClearPoint Neuro: Fundamentals Continue To Strengthen

Apr 28, 2025, 8:00 AM EDT - 6 months ago

ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI

Apr 25, 2025, 8:00 AM EDT - 6 months ago

ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025

Apr 24, 2025, 8:00 AM EDT - 6 months ago

ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 - Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room

Feb 27, 2025, 11:18 PM EST - 8 months ago

ClearPoint Neuro: Drug Delivery Prospects Continue To Strengthen

Feb 26, 2025, 7:17 PM EST - 8 months ago

ClearPoint Neuro, Inc. (CLPT) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 4:05 PM EST - 8 months ago

ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results

Feb 14, 2025, 8:00 AM EST - 9 months ago

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025

Feb 12, 2025, 4:15 PM EST - 9 months ago

ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula

Jan 27, 2025, 4:05 PM EST - 9 months ago

ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0

Nov 13, 2024, 6:15 PM EST - 1 year ago

ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain

Nov 10, 2024, 9:35 AM EST - 1 year ago

ClearPoint Neuro: Near-Term Volatility Is No Concern

Nov 7, 2024, 10:31 PM EST - 1 year ago

ClearPoint Neuro, Inc. (CLPT) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:05 PM EST - 1 year ago

ClearPoint Neuro Reports Third Quarter 2024 Results

Oct 31, 2024, 4:05 PM EDT - 1 year ago

ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024

Oct 17, 2024, 4:05 PM EDT - 1 year ago

ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024

Aug 26, 2024, 4:05 PM EDT - 1 year ago

ClearPoint Neuro Announces Early Repayment of $10 Million Note

Aug 14, 2024, 9:33 AM EDT - 1 year ago

ClearPoint: Growth Tailwinds Are Only Just Beginning To Emerge (Rating Downgrade)

Aug 8, 2024, 7:39 PM EDT - 1 year ago

ClearPoint Neuro: My Favorite Growth Stock

Aug 8, 2024, 7:25 AM EDT - 1 year ago

ClearPoint Neuro, Inc. (CLPT) Q2 2024 Earnings Call Transcript

Jul 17, 2024, 4:05 PM EDT - 1 year ago

ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024

Jun 21, 2024, 5:11 AM EDT - 1 year ago

ClearPoint Neuro: Solid Progress Still Not Reflected In The Share Price

Jun 20, 2024, 8:45 AM EDT - 1 year ago

ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial

Jun 20, 2024, 8:30 AM EDT - 1 year ago

Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons

Jun 1, 2024, 9:00 AM EDT - 1 year ago

ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System

May 7, 2024, 10:40 PM EDT - 1 year ago

ClearPoint Neuro, Inc. (CLPT) Q1 2024 Earnings Call Transcript

Apr 25, 2024, 2:30 AM EDT - 1 year ago

ClearPoint Neuro: Macro-Induced Multiple Compression

Apr 16, 2024, 4:05 PM EDT - 1 year ago

ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations

Mar 19, 2024, 8:07 AM EDT - 1 year ago

ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC Deficiency

Mar 12, 2024, 11:39 PM EDT - 1 year ago

ClearPoint Neuro, Inc. (CLPT) Q4 2023 Earnings Call Transcript

Mar 12, 2024, 4:05 PM EDT - 1 year ago

ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results

Mar 1, 2024, 4:05 PM EST - 1 year ago

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024

DekmarTrades Oct. 27 at 3:33 PM

$RKLB $CLPT $BWXT 4pm Today.

1 · Reply

mhill771 Oct. 26 at 5:11 PM

$CLPT 50 in due time

0 · Reply

makny Oct. 24 at 3:22 PM

$CLPT this has become an ideal stock for day trade, giving at least $0.50 daily.

0 · Reply

DekmarTrades Oct. 24 at 2:28 PM

$RKLB $CLPT $BWXT I will be 100% giving this Alert away on Monday. I just want to do some final research first. It is important to me that if I make a statement like this, I back it up.

3 · Reply

HiIdontcareThx Oct. 24 at 1:51 PM

$CLPT long-time bull. Added more.

1 · Reply

junboi Oct. 24 at 12:57 PM

$BWXT $CLPT $RKLB oops didn’t add you @DekmarTrades

0 · Reply

junboi Oct. 24 at 12:54 PM

1 · Reply

NY2CHI Oct. 24 at 12:26 AM

$CLPT recognized in Time as a growth leader in USA https://time.com/7327022/americas-growth-leaders-2025/

0 · Reply

DekmarTrades Oct. 23 at 9:57 PM

8 · Reply

NY2CHI Oct. 23 at 7:01 PM

0 · Reply

NY2CHI Oct. 23 at 6:58 PM

$CLPT remember @Twister8 , aka, basement dwelling TJ, thought this was too pricey, 800% ago...

1 · Reply

Twister8 Oct. 23 at 5:31 PM

$CLPT Joe deserves some credit for pivoting out of the iMRI suite as that was always going to be a low revenue producing pursuit...

1 · Reply

Twister8 Oct. 23 at 3:18 PM

$CLPT remember when they would break out the number of cases performed each quarter? I was the one who told them to do it and Ironically, I am the reason they stopped...good times.

1 · Reply

NY2CHI Oct. 22 at 8:14 PM

$CLPT imagine seeeing this, and being like, yeah I’m going to short the market leader in this growing space… https://www.globenewswire.com/news-release/2025/10/22/3170850/0/en/Image-Guided-Drug-Delivery-Research-and-Forecast-Report-2025-2035-AI-Assisted-Infusion-Planning-MRI-Compatible-Robotics-and-Multimodal-Imaging-Innovations-Fuel-Expansion.html

1 · Reply

NY2CHI Oct. 22 at 7:50 PM

$CLPT another epically stupid investment idea by the ultimate clown of ST, @Twister8 . Many more where this came from TJ. Now, go to your room.

0 · Reply

NY2CHI Oct. 22 at 7:45 PM

$CLPT the narcissist traderjoe aka @Twister8 back in 2020. Don't feel bad for people who say stupid shit like this... "shouldn't have resisted my foresight, it will cost you" BAHAHAHAHAHA dude, we're up 800% since your goofy, narcissistic ass posted this crap. You literally can't be this wrong even if you try. It's actually impressive how terrible you are at understanding business and markets.

0 · Reply

RichSaunder Oct. 22 at 7:17 PM

$CLPT Wow thanks man, yahoo finance has been able to show us these since the 90s, you don’t have to post them.

0 · Reply

RichSaunder Oct. 22 at 7:09 PM

$CLPT TraderJoe has changed names like 5 times bc his previous posts are always wrong. He’s told you to buy MDT over and over. CLPT is up 830% vs MDT 19% since Joe B bc CLPT CEO. Great call bud.

0 · Reply

healthcareguru Oct. 22 at 5:46 PM

$CLPT back to $15, suckers…learn math and how to forecast/value an asset. Your funeral. 🐺👎

2 · Reply

Twister8 Oct. 22 at 4:20 PM

$CLPT so the CLPT fate is in the hands of one of their bio pharma customers hitting it big with a large indication commercial approval? A parasitic/host relationship bet, no?

1 · Reply

Twister8 Oct. 22 at 3:30 PM

$CLPT Latest Quarterly Results (Q2 2025) Total Revenue: $9.2 million (an increase of 17% year-over-year). Gross Margin: 60% (down from 63% in Q2 2024). Operating Loss: -$5.7 million (compared to -$4.7 million in Q2 2024). Net Loss: -$5.8 million (compared to -$4.4 million in Q2 2024). Earnings Per Share (EPS): -$0.21 (vs. -$0.16 in Q2 2024). Cash and Cash Equivalents (as of June 30, 2025): $41.5 million.

1 · Reply

nomen Oct. 22 at 2:32 PM

$CLPT MRI Guided CED market estimates going from 60mm this year to 900mm in 2035… guess who is the leader on the space

1 · Reply

Market Cap	703.28M
Revenue (ttm)	31.39M
Net Income (ttm)	-18.91M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-60.24%
Debt to Equity Ratio	1.46

Volume	321,027
Avg Vol	932,578
Day's Range	N/A - N/A
Shares Out	28.43M
Stochastic %K	27%
Beta	1.19
Analysts	Strong Sell
Price Target	$29.00